DevelopMed MSCA COFUND Call 3 Now Open!

Published 1st May 2023


Call 3 of the ‘Developing the Next Generation of Research Leaders in Precision Oncology’ (DevelopMed) Marie Sklodowska-Curie COFUND Programme is now officially open with a closing date of 25 June 2023. The programme offers prestigious precision oncology fellowships to experienced researchers at the early stage of their careers.

DevelopMed, which is coordinated by Systems Biology Ireland (SBI) in UCD, entails an EU investment of €1.32 million. DevelopMed is a training programme that will support the development of high-calibre research fellows who are at an early stage of their careers. Fellows will be conducting research throughout Ireland in precision oncology within the themes of Diagnostics, Therapeutics & Drug Development, and the Tumour Microenvironment. Proposals may be in basic or applied research topics broadly classified within the aforementioned precision oncology themes (e.g. computational modelling, nutrition, obesity, machine learning, immunology etc). Fellowships in Call 3 will be 24 months in duration.

The aim of DevelopMed is to develop the next generation of skilled researchers who will gain hands-on experience developing cross-disciplinary and entrepreneurial skills through individual research projects with a mandatory 3-6 month secondment at an accredited research organisation (academic, industrial, clinical and/or charity sectors) during their fellowship. DevelopMed Fellowships are for experienced researchers of any nationality residing worldwide, seeking a prestigious career development fellowship based in one of four leading Irish universities. Institutions hosting fellows include University College Dublin, the University of Galway, University College Cork, and the RCSI University of Medicine and Health Sciences.

Fellowships include the opportunity to work closely with a number of relevant academic and non-academic partners of their choice and appropriate to their research, training, and professional career development. Information on eligibility criteria for applicants can be found here.

Furthermore, the DevelopMed programme supports gender equality in research and innovation. All DevelopMed academic partners have signed the Athena SWAN Charter, established to encourage and recognise commitment to advancing the careers of women in science, technology, engineering, maths and medicine (STEMM) employment in research.

Each DevelopMed fellow will be working with one or two academic supervisors. More information on Call 3’s list of academic supervisors and their research focus areas can be found here.

To learn more about the DevelopMed programme, the application process and how to apply, visit, follow us on Twitter at @DevelopMed_MSCA or contact us at